The novel anticonvulsant lamotrigine prevents dopamine depletion in C57 black mice in the MPTP animal model of Parkinson's disease

This publication has 26 references indexed in Scilit:

• Partial protective effect of MK-801 on MPTP-induced reduction of striatal dopamine in mice
  Neuroscience Letters, 1992
• Neurochemical and Behavioral Aspects of Lamotrigine
  Epilepsia, 1991
• Time course of MPTP-induced degeneration of the nigrostriatal dopamine system in C57 BL/6 mice
  Brain Research Bulletin, 1988
• Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57 BL/6 mice. Comparison with three other strains of mice
  Brain Research, 1987
• Pharmacological Studies on Lamotrigine, A Novel Potential Antiepileptic Drug
  Epilepsia, 1986
• Pharmacological Studies on Lamotrigine, A Novel Potential Antiepileptic Drug
  Epilepsia, 1986
• Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes
  Biochemical and Biophysical Research Communications, 1985
• Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP
  European Journal of Pharmacology, 1984
• Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
  Nature, 1984
• Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism
  Nature, 1984